Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-04-01
DOI
10.1038/srep04554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apocynin suppresses the progression of atherosclerosis in apoE-deficient mice by inactivation of macrophages
- (2013) Hiroyuki Kinoshita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
- (2013) Akira Sezai et al. CIRCULATION JOURNAL
- Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients With or Without Gout: A Systematic Review and Meta-Analysis
- (2013) Peng Ye et al. CLINICAL THERAPEUTICS
- Inflammasomes: sensors of metabolic stresses for vascular inflammation
- (2013) Xiao-feng Yang Frontiers in Bioscience-Landmark
- CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
- (2013) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- Fatty acid–induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis
- (2013) Stefan Freigang et al. NATURE IMMUNOLOGY
- Oxidized Low Density Lipoprotein Induced Caspase-1 Mediated Pyroptotic Cell Death in Macrophages: Implication in Lesion Instability?
- (2013) Jing Lin et al. PLoS One
- Febuxostat, an Inhibitor of Xanthine Oxidase, Suppresses Lipopolysaccharide-Induced MCP-1 Production via MAPK Phosphatase-1-Mediated Inactivation of JNK
- (2013) Johji Nomura et al. PLoS One
- Arginase: The Emerging Therapeutic Target for Vascular Oxidative Stress and Inflammation
- (2013) Zhihong Yang et al. Frontiers in Immunology
- Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction
- (2013) Michael Madigan et al. Frontiers in Immunology
- Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice
- (2012) Jong-Gil Park et al. ATHEROSCLEROSIS
- Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice
- (2012) Fumitake Usui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endothelial dysfunction : the early predictor of atherosclerosis
- (2012) Mashudu Mudau et al. Cardiovascular Journal of Africa
- Actions of “antioxidants” in the protection against atherosclerosis
- (2012) Maria E. Lönn et al. FREE RADICAL BIOLOGY AND MEDICINE
- Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica
- (2012) Caiyan Liu et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Lack of association between serum uric acid levels and outcome in acute ischemic stroke
- (2012) Irene Miedema et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Atherosclerosis: from biology to pharmacological treatment
- (2012) Riccioni Graziano et al. Journal of Geriatric Cardiology
- Xanthine Oxidoreductase Is Involved in Macrophage Foam Cell Formation and Atherosclerosis Development
- (2011) Akifumi Kushiyama et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nitric oxide synthases: regulation and function
- (2011) U. Forstermann et al. EUROPEAN HEART JOURNAL
- Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis
- (2011) Stefan Freigang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Febuxostat inhibition of endothelial-bound XO: Implications for targeting vascular ROS production
- (2011) Umair Z. Malik et al. FREE RADICAL BIOLOGY AND MEDICINE
- The inflammasome: an integrated view
- (2011) Olaf Gross et al. IMMUNOLOGICAL REVIEWS
- The immune system in atherosclerosis
- (2011) Göran K Hansson et al. NATURE IMMUNOLOGY
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
- (2011) P Menu et al. Cell Death & Disease
- Efficacy and safety of febuxostat in patients with hyperuricemia and gout
- (2011) Ignacio Garcia-Valladares et al. Therapeutic Advances in Musculoskeletal Disease
- Is oxidative stress a therapeutic target in cardiovascular disease?
- (2010) Thomas Münzel et al. EUROPEAN HEART JOURNAL
- Serum uric acid levels and neuromyelitis optica
- (2010) Fuhua Peng et al. JOURNAL OF NEUROLOGY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
- (2010) Kristiina Rajamäki et al. PLoS One
- Uric Acid Levels Are Relevant in Patients With Stroke Treated With Thrombolysis
- (2010) S. Amaro et al. STROKE
- N-Acetylcysteine Reduces the Severity of Atherosclerosis in Apolipoprotein E-Deficient Mice by Reducing Superoxide Production
- (2009) Kana Shimada et al. CIRCULATION JOURNAL
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase
- (2008) Tomoko Nishino et al. FEBS Journal
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started